Faron Pharmaceuticals Oy (OTCPK:FPHAF)
$ 3.3 0 (0%) Market Cap: 215.14 Mil Enterprise Value: 221.88 Mil PE Ratio: 0 PB Ratio: 138.64 GF Score: 38/100

Half Year 2021 Faron Pharmaceuticals Oy Earnings Call Transcript

Aug 26, 2021 / 11:00AM GMT
Release Date Price: $5.25
Dr. Markku Jalkanen
Faron Pharmaceuticals Oy - CEO

Good afternoon and good morning for those in US, and thank you for joining us. This conference call is where we go over the presentation for the first six months of this year. It would be great and nice to see you all, but obviously we need to survive and try to do it this way but hope to really soon get over this one. I'm here also with our CFO, Toni Hänninen, who is in Zürich. Hello, Toni.

Toni HÃ;nninen
Faron Pharmaceuticals Oy - CFO

¤ -

Good morning and good afternoon.

Dr. Markku Jalkanen
Faron Pharmaceuticals Oy - CEO

And with that, could I get the next slide, please? That is just to remind -- slide number two, please -- just to remind you that there will be some forward-looking statements during the presentation, and this is just the disclaimer, of course. Next slide, please.

So, as you know, we really have been focusing on the immunotherapies where we maximize the system, we have to defend ourselves (inaudible). Our main target is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot